Initial investment in REMS means big pay-put for pharma, says RAPS author

EXPLORE

Society & Culture

© 2024 PodJoint

00:00 / 00:00

Sign in

or

Don't have an account?

Sign up

Forgot password

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/5a/2c/37/5a2c3765-fa3c-6e8d-73aa-a7c7b47f151d/mza_6654900394461786230.jpeg/600x600bb.jpg

Outsourcing-Pharma Podcast

William Reed Ltd

120 episodes

8 months ago

Breaking News on Outsourcing Pharma

Show more...

All content for Outsourcing-Pharma Podcast is the property of William Reed Ltd and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Breaking News on Outsourcing Pharma

Show more...

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/5a/2c/37/5a2c3765-fa3c-6e8d-73aa-a7c7b47f151d/mza_6654900394461786230.jpeg/600x600bb.jpg

Initial investment in REMS means big pay-put for pharma, says RAPS author

Outsourcing-Pharma Podcast

5 minutes

13 years ago

Initial investment in REMS means big pay-put for pharma, says RAPS author

A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor.

Outsourcing-Pharma Podcast

Breaking News on Outsourcing Pharma